The Lancet: Benralizumab injections reduce exacerbations in severe, uncontrolled asthma, according to 2 trials

(The Lancet) A year's course of benralizumab injections has led to a significant decrease in the frequency of asthma exacerbations -- cutting the rate of exacerbations by a third to a half compared with placebo among people with the most severe form of asthma, according to two phase 3, double-blind, randomized controlled trials including more than 2,500 patients in total.